B of A Securities Maintains Neutral on Chemed, Raises Price Target to $510
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:CHE) with a Neutral and raises the price target from $450 to $510.
B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:CHE) with a Neutral and raises the price target from $450 to $510.